Donald Castell to Enzyme Inhibitors
This is a "connection" page, showing publications Donald Castell has written about Enzyme Inhibitors.
Connection Strength
1.649
-
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun; 120(7):1599-606.
Score: 0.147
-
Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Aliment Pharmacol Ther. 2001 May; 15(5):647-52.
Score: 0.146
-
Aggressive acid control: minimizing progression of Barrett's esophagus. Am J Manag Care. 2001 Feb; 7(1 Suppl):S15-8.
Score: 0.144
-
Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther. 2000 Oct; 14(10):1267-72.
Score: 0.140
-
Total acid suppression and its effect on Barrett's esophagus. Am J Manag Care. 2000 Oct; 6(16 Suppl):S895-8.
Score: 0.140
-
Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. Aliment Pharmacol Ther. 1999 Nov; 13(11):1467-71.
Score: 0.132
-
Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther. 1999 Sep; 13(9):1211-4.
Score: 0.130
-
The acid suppression test for unexplained chest pain. Gastroenterology. 1998 Jul; 115(1):222-4.
Score: 0.120
-
Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Am J Gastroenterol. 1997 Dec; 92(12):2329-30.
Score: 0.115
-
Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol. 1996 Oct; 91(10):2110-3.
Score: 0.106
-
Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol. 1996 Sep; 91(9):1749-57.
Score: 0.106
-
Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers. Clin Ther. 2006 May; 28(5):725-33.
Score: 0.052
-
Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.
Score: 0.050
-
Medical therapy of supraesophageal gastroesophageal reflux disease. Am J Med. 2000 Mar 06; 108 Suppl 4a:170S-177S.
Score: 0.034
-
Medical therapy. Management of the refractory patient. Gastroenterol Clin North Am. 1999 Dec; 28(4):847-60.
Score: 0.033
-
Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD). Semin Thorac Cardiovasc Surg. 1997 Apr; 9(2):169-72.
Score: 0.028
-
Health-related quality of life of patients with acute erosive reflux esophagitis. Dig Dis Sci. 1996 Nov; 41(11):2123-9.
Score: 0.027